A Controlled Trial to Investigate the Efficacy and Safety of Frovatriptan to Prevent Menstrual Migraine
Clinical trial NCT00475514 · COMPLETED
Trial details
- NCT number
- NCT00475514
- Sponsor
- Endo USA Inc., a Keenova Therapeutics Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-10-01
- Primary completion
- 2006-03-01
- Enrollment
- 500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.